This session will present the main gaps and cross-cutting priorities identified across the MCM Preparedness Roadmaps (on pandemic influenza, filoviruses, dengue, carbapenem-resistant Enterobacterales and nerve agents, representing respiratory, direct-contact, vector-borne, antimicrobial-resistant and CBRN threats) and discuss them with organisations involved throughout the MCM lifecycle—from public-health needs assessment and product development to regulation, manufacturing, procurement and deployment.
Session
Turning MCM Needs into Action: Industry Dialogue on HERA’s Preparedness Roadmaps
Date: Tuesday, 24 November 2026
Time: 15:50-17:05
Room: Studio
Speakers include:
- Ana Burgos, Head of Unit HERA 04 – intelligence, innovation and funding, European Commission
- Rudi Paye, Strategy & Operations Director, DNDi
- Jean-Baptiste Perrin, Deputy Head of Unit, European Commission
- Peter Beyer, Deputy Executive Director, GARDP
- Mark Feinberg, President and CEO, IAVI (International AIDS Vaccine Initiative)
